This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Berenberg Bank Sticks to Their Hold Rating for Qiagen (QGEN)

Tipranks - Tipranks - Sun Oct 25, 10:40AM CDT

In a report released on October 22, Harry Gillis from Berenberg Bank maintained a Hold rating on Qiagen, with a price target of €46.50. The company’s shares closed yesterday at $50.22.

Gillis covers the Healthcare sector, focusing on stocks such as Qiagen, Tecan Group AG, and BioNTech SE. According to TipRanks, Gillis has an average return of 22.6% and a 70.15% success rate on recommended stocks.

In addition to Berenberg Bank, Qiagen also received a Hold from J.P. Morgan’s Casey Woodring in a report issued on October 22. However, on the same day, Deutsche Bank maintained a Buy rating on Qiagen (NYSE: QGEN).

See Insiders’ Hot Stocks on TipRanks >>

Based on Qiagen’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $535.04 million and a net profit of $103.4 million. In comparison, last year the company earned a revenue of $533.54 million and had a net profit of $96.25 million

Read More on QGEN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

Market data (will open in new tab) provided by Barchart. Exchange delay details and data provider terms here. Information may be delayed, is provided 'as is' and is solely for informational purposes, and not for trading, investment or advice.